COVID-19 human challenge studies in the UK

Type Journal Article Author Tony Kirby URL https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30518-X/abstract Series News Publication The Lancet Respiratory Medicine ISSN 2213-2600, 2213-2619 Date 30/10/2020 Extra Publisher: Elsevier PMID: 33137284 Journal Abbr The Lancet Respiratory Medicine DOI 10.1016/S2213-2600(20)30518-X Library Catalog www.thelancet.com Language English Abstract The Human Challenge Consortium consists of UK Government representatives and experts from the National Health Service (NHS), academia, and the private sector. The group has come together to explore the feasibility and ethics of human challenge trials that could potentially accelerate the development of vaccines to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.